Liraglutide Dosing & Reconstitution Guide
Dosing Protocol
Route: Subcutaneous Frequency: Once daily Dose Range: Saxenda: 0.6-3.0 mg/day; Victoza: 0.6-1.8 mg/day Cycle Length: Ongoing; discontinue if <4% weight loss at 16 weeks on 3.0 mg Timing: Any time of day, with or without meals, consistent daily
Titration Schedule
Week 1: 0.6 mg daily Week 2: 1.2 mg daily Week 3: 1.8 mg daily Week 4: 2.4 mg daily Week 5+ (maintenance): 3.0 mg daily (Saxenda)
Storage
Lyophilized: N/A (pre-filled pen) Reconstituted: 2-8 °C before first use; room temperature up to 30 days in use Shelf Life: 30 days
Injection Sites
Abdomen, Thigh, Upper arm
Safety & Contraindications
Safety: Common: nausea (39%), diarrhea (21%), constipation (19%), vomiting (15%), headache (13%) GI side effects are dose-dependent and typically diminish over weeks FDA black box warning for thyroid C-cell tumors (rodent data)
Contraindications: Personal or family history of medullary thyroid carcinoma; Multiple endocrine neoplasia syndrome type 2 (MEN2); History of pancreatitis